Results
|
|
2681.
|
|
|
|
2682.
|
|
|
|
2683.
|
|
|
|
2684.
|
|
|
|
2685.
|
Off-target effects of c-MET inhibitors on thyroid cancer cells. [electronic resource] by
- Zhou, Yan
- Zhao, Conghui
- Gery, Sigal
- Braunstein, Glenn D
- Okamoto, Ryoko
- Alvarez, Rocio
- Miles, Steven A
- Doan, Ngan B
- Said, Jonathan W
- Gu, Jiang
- Phillip Koeffler, H
Producer: 20140929
In:
Molecular cancer therapeutics vol. 13
Availability: No items available.
|
|
|
2686.
|
MET and EGFR mutations identified in ALK-rearranged pulmonary adenocarcinoma: molecular analysis of 25 ALK-positive cases. [electronic resource] by
- Boland, Jennifer M
- Jang, Jin Sung
- Li, Jun
- Lee, Adam M
- Wampfler, Jason A
- Erickson-Johnson, Michele R
- Soares, Ibere
- Yang, Ping
- Jen, Jin
- Oliveira, Andre M
- Yi, Eunhee S
Producer: 20131224
In:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 8
Availability: No items available.
|
|
|
2687.
|
|
|
|
2688.
|
Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice. [electronic resource] by
- Kroy, Daniela C
- Schumacher, Fabienne
- Ramadori, Pierluigi
- Hatting, Maximilian
- Bergheim, Ina
- Gassler, Nikolaus
- Boekschoten, Mark V
- Müller, Michael
- Streetz, Konrad L
- Trautwein, Christian
Producer: 20150804
In:
Journal of hepatology vol. 61
Availability: No items available.
|
|
|
2689.
|
|
|
|
2690.
|
|
|
|
2691.
|
Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844). [electronic resource] by
- Ugolini, Antonio
- Kenigsberg, Mireille
- Rak, Alexey
- Vallée, Francois
- Houtmann, Jacques
- Lowinski, Maryse
- Capdevila, Cécile
- Khider, Jean
- Albert, Eva
- Martinet, Nathalie
- Nemecek, Conception
- Grapinet, Sandrine
- Bacqué, Eric
- Roesner, Manfred
- Delaisi, Christine
- Calvet, Loreley
- Bonche, Fabrice
- Semiond, Dorothée
- Egile, Coumaran
- Goulaouic, Hélène
- Schio, Laurent
Producer: 20170612
In:
Journal of medicinal chemistry vol. 59
Availability: No items available.
|
|
|
2692.
|
Functional and therapeutic relevance of hepatocyte growth factor/c-MET signaling in synovial sarcoma. [electronic resource] by
- Imura, Yoshinori
- Nakai, Takaaki
- Yamada, Shutaro
- Outani, Hidetatsu
- Takenaka, Satoshi
- Hamada, Kenichiro
- Araki, Nobuhito
- Itoh, Kazuyuki
- Yoshikawa, Hideki
- Naka, Norifumi
Producer: 20170206
In:
Cancer science vol. 107
Availability: No items available.
|
|
|
2693.
|
MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation. [electronic resource] by
- Noro, Rintaro
- Seike, Masahiro
- Zou, Fenfei
- Soeno, Chie
- Matsuda, Kuniko
- Sugano, Teppei
- Nishijima, Nobuhiko
- Matsumoto, Masaru
- Kitamura, Kazuhiro
- Kosaihira, Seiji
- Minegishi, Yuji
- Yoshimura, Akinobu
- Kubota, Kaoru
- Gemma, Akihiko
Producer: 20160128
In:
BMC cancer vol. 15
Availability: No items available.
|
|
|
2694.
|
Correlation between MET protein expression and MET gene copy number in a Caucasian cohort of non-small cell lung cancers according to the new IASLC/ATS/ERS classification. [electronic resource] by
- Weingertner, Noëlle
- Meyer, Nicolas
- Voegeli, Anne-Claire
- Guenot, Dominique
- Renaud, Stéphane
- Massard, Gilbert
- Falcoz, Pierre-Emmanuel
- Olland, Anne
- Mennecier, Bertrand
- Gaub, Marie-Pierre
- Lindner, Véronique
- Ghnassia, Jean-Pierre
- Quoix, Elisabeth
- Chenard, Marie-Pierre
- Beau-Faller, Michèle
Producer: 20160422
In:
Pathology vol. 47
Availability: No items available.
|
|
|
2695.
|
MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2. [electronic resource] by
- Ren, X L
- He, G Y
- Li, X M
- Men, Hui
- Yi, L Z
- Lu, G F
- Xin, S N
- Wu, P X
- Li, Y L
- Liao, W T
- Ding, Y Q
- Liang, L
Producer: 20160629
In:
Journal of cancer research and clinical oncology vol. 142
Availability: No items available.
|
|
|
2696.
|
|
|
|
2697.
|
Reversal of c-MET-mediated Resistance to Cytotoxic Anticancer Drugs by a Novel c-MET Inhibitor TAS-115. [electronic resource] by
- Kunii, Eiji
- Ozasa, Hiroaki
- Oguri, Tetsuya
- Maeno, Ken
- Fukuda, Satoshi
- Uemura, Takehiro
- Takakuwa, Osamu
- Ohkubo, Hirotsugu
- Takemura, Masaya
- Niimi, Akio
Producer: 20160104
In:
Anticancer research vol. 35
Availability: No items available.
|
|
|
2698.
|
Susceptibility of pancreatic cancer stem cells to reprogramming. [electronic resource] by
- Noguchi, Kozo
- Eguchi, Hidetoshi
- Konno, Masamitsu
- Kawamoto, Koichi
- Nishida, Naohiro
- Koseki, Jun
- Wada, Hiroshi
- Marubashi, Shigeru
- Nagano, Hiroaki
- Doki, Yuichiro
- Mori, Masaki
- Ishii, Hideshi
Producer: 20151215
In:
Cancer science vol. 106
Availability: No items available.
|
|
|
2699.
|
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'. [electronic resource] by
- Schöffski, P
- Wozniak, A
- Stacchiotti, S
- Rutkowski, P
- Blay, J-Y
- Lindner, L H
- Strauss, S J
- Anthoney, A
- Duffaud, F
- Richter, S
- Grünwald, V
- Leahy, M G
- Reichardt, P
- Sufliarsky, J
- van der Graaf, W T
- Sciot, R
- Debiec-Rychter, M
- van Cann, T
- Marréaud, S
- Lia, M
- Raveloarivahy, T
- Collette, L
- Bauer, S
Producer: 20180502
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
|
2700.
|
|